Latest news
Loading news…
Protyon
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Groningen, The Netherlands Founded 2022 1-10 employees For Profit
Protyon provides an analysis service examines the effect of mutations in specific proteins targeted for treatment in lung cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Patents
1
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 31
- Patents granted
- 1
- Trademarks
- 1
- IT spend
- $231K
Company Info
- Founded
- 2022
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- HQ
- Groningen, The Netherlands
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.3
- Trend (90d)
- -0.9
2
professional contacts at Protyon
Contact execs at Protyon →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Protyon
Loading news…
FAQs about Protyon
People who checked this page also checked these
Browse the full Acquirezy directory.